Search for: "Mylan, Inc."
Results 181 - 200
of 673
Sort by Relevance
|
Sort by Date
18 Aug 2017, 2:15 pm
Mylan Inc., et al.. [read post]
18 Aug 2017, 2:15 pm
Mylan Inc., et al.. [read post]
18 Aug 2017, 2:15 pm
Mylan Inc., et al.. [read post]
21 Jul 2017, 8:15 am
Mylan, Inc and Skedco, Inc. v. [read post]
17 Jul 2017, 9:41 am
Par Pharm., Inc. v. [read post]
21 May 2017, 5:39 pm
Sciele Pharma, Inc. v. [read post]
14 May 2017, 9:55 pm
Mylan Pharmaceuticals, Inc. v. [read post]
18 Apr 2017, 6:52 am
Mylan, 2017 U.S. [read post]
12 Apr 2017, 9:52 am
(collectively, Novartis).The Board instituted IPRs on all claims of the ’283 patentbased on petitions filed by Torrent PharmaceuticalsLimited, Apotex, Inc. and Mylan Pharmaceuticals Inc. [read post]
12 Apr 2017, 8:44 am
Torrent Pharma, Apotex, and Mylan (Fed. [read post]
12 Apr 2017, 4:15 am
Mylan, Inc. (2015-1113, 2015-1151, and 2015-1181) that imports certain subject matter from the specification into the claims... [read post]
9 Apr 2017, 9:59 pm
Noonan -- The Federal Circuit returned to its consideration of the outcome in the District Court of The Medicines Company's ANDA litigation against Mylan and Bioniche Pharma over a proposed generic version of Medicines' bivalirudin drug (sold as Angiomax®), an anticoagulant used in heart surgery. [read post]
6 Apr 2017, 1:35 pm
Mylan, Inc., No. 15-1113(Fed. [read post]
8 Feb 2017, 3:09 am
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
31 Jan 2017, 8:55 pm
§ 102(f), in Cumberland Pharmaceuticals Inc. v. [read post]
26 Jan 2017, 9:23 am
Cir. 2013);Slip Track Sys., Inc. v. [read post]
16 Jan 2017, 5:44 pm
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
21 Dec 2016, 7:18 am
Mylan Pharmaceutical Inc. says they expect PTAB decisions on the IPRs sometime during the fourth quarter of 2017. [read post]
7 Dec 2016, 9:59 pm
Mylan Pharmaceuticals Inc. v. [read post]
14 Nov 2016, 2:01 pm
As previously reported, Mylan Inc., the pharmaceutical manufacturer of the life-saving EpiPen, misclassified their brand name drug as generic for years, thus deceiving and effectively defrauding governmentally-funded insurance providers Medicare and Medicaid, resulting in millions of dollars in overpayments by taxpayers, all in an effort to save themselves money prior to hiking the price of The post EpiFail: Gov’t Knew EpiPen Was Misclassified in 2009 appeared first on Legal… [read post]
